Induced regulatory T cells as immunotherapy in allotransplantation and autoimmunity: challenges and opportunities
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae062 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Evelyn Katy Alvarez-Salazar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and National Laboratory of Flow Cytometry, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México,…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Autoimmunity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 192 Literaturangaben. Gefördert von: CONACyT.
Abstract (Originalsprache)
Regulatory T cells play a crucial role in the homeostasis of the immune response. Regulatory T cells are mainly generated in the thymus and are characterized by the expression of Foxp3, which is considered the regulatory T-cell master transcription factor. In addition, regulatory T cells can be induced from naive CD4+ T cells to express Foxp3 under specific conditions both in vivo (peripheral regulatory T cells) and in vitro (induced regulatory T cells). Both subsets of thymic regulatory T cells and peripheral regulatory T cells are necessary for the establishment of immune tolerance to self and non-self antigens. Although it has been postulated that induced regulatory T cells may be less stable compared to regulatory T cells, mainly due to epigenetic differences, accumulating evidence in animal models shows that induced regulatory T cells are stable in vivo and can be used for the treatment of inflammatory disorders, including autoimmune diseases and allogeneic transplant rejection. In this review, we describe the biological characteristics of induced regulatory T cells, as well as the key factors involved in induced regulatory T-cell transcriptional, metabolic, and epigenetic regulation, and discuss recent advances for de novo generation of stable regulatory T cells and their use as immunotherapeutic tools in different experimental models. Moreover, we discuss the challenges and considerations for the application of induced regulatory T cells in clinical trials and describe the new approaches proposed to achieve in vivo stability, including functional or metabolic reprogramming and epigenetic editing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and National Laboratory of Flow Cytometry, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Circuito Escolar s/n, Ciudad Universitaria, Colonia Copilco, Delegaci…
ORCID-Profile: Gloria Soldevila
Förderung
- CONACyT
Zitieren
APA
Alvarez-Salazar, E. K., Cortés-Hernández, A., Arteaga-Cruz, S., & Soldevila, G. (2024). Induced regulatory T cells as immunotherapy in allotransplantation and autoimmunity: challenges and opportunities. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae062
Vancouver
Alvarez-Salazar EK, Cortés-Hernández A, Arteaga-Cruz S, Soldevila G. Induced regulatory T cells as immunotherapy in allotransplantation and autoimmunity: challenges and opportunities. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae062
BibTeX
@article{AlvarezSalazar2024,
author = {Alvarez-Salazar, Evelyn Katy and Cortés-Hernández, Arimelek and Arteaga-Cruz, Saúl and Soldevila, Gloria},
title = {Induced regulatory T cells as immunotherapy in allotransplantation and autoimmunity: challenges and opportunities},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae062}
}
EUVIMED